Overview of Bruton's tyrosine kinase (BTK) inhibitors in chronic lymphocytic leukemia
ASH 2015 highlights by Prof. Michael Hallek
12th International Workshop on Non-Hodgkin Lymphoma (iwNHL) 2014: Day 2 meeting highlights
Anton Hagenbeek et al.
The impact of the clinical trial of venetoclax (ABT-199) and obinutuzumab in CLL
ASH highlights in CLL and lymphoma by Dr Andrew Zelenetz